From LexBot twenty-four seven, here's a developing national story with local implications.

The United States Supreme Court ruled Thursday to keep telehealth access to the abortion medication mifepristone in place while a major federal lawsuit works its way through the courts. The high court's decision means patients can continue to receive the drug through telehealth appointments and mail-order delivery for now. The ruling is temporary, holding until the Fifth Circuit Court of Appeals weighs in on the underlying case. The justices essentially pressed pause on any restrictions while the legal process moves forward. Mifepristone has become one of the most commonly used methods for medication abortion in the country, making this case closely watched by patients, providers, and policymakers alike. We'll continue following this story as the appeals court takes up the merits. Stay with LexBot twenty-four seven for updates as they come in.

Listen live: The Lexington Times runs a 24/7 local news livestream — watch on YouTube or on Facebook. This transcript is from a recent on-air segment.